Donald A. Bergstrom, President, R&D at Relay Therapeutics, Inc. (RLAY), sold 157,680 shares at $4.42 ($710K) on 2025-01-30, disclosed to the SEC on 2025-01-30.
Seasonal sale ($710k) by President, R&D — this insider has traded RLAY in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.63 | 3,220 | $15K | 2.1% |
| 2 | $4.55 | 46,407 | $211K | 29.8% |
| 3 | $4.55 | 46,407 | $211K | 29.8% |
| 4 | $4.42 | 30,823 | $136K | 19.2% |
| 5 | $4.42 | 30,823 | $136K | 19.2% |
| Total | $4.50 avg | 157,680 |
| $710K |
| 100% |
| Filing → |
| RLAY | SELL | 2026-07-08 | $162K | — | Filing → |
| RLAY | SELL | 2026-06-24 | $1.6M | — | Filing → |
| RLAY | SELL | 2026-04-30 | $22K | — | Filing → |